13 March 2022 | News
Feedback and remarks of the Industry and stakeholders are invited till the 25th of March 2022
image credit- adobestock
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers has released on its website, an Approach Paper for the Draft National Policy for the Medical Devices, 2022, inviting feedback and remarks of the Industry and stakeholders, till the 25th of March 2022.
This policy, while addressing the core objectives of accessibility, affordability, safety and quality, focuses on self-sustainability and innovation.
The salient features include regulatory streamlining; quality standards and safety of the devices; building competitiveness through fiscal and financial support; infrastructure development; facilitating R&D and innovation; human resource development; and awareness creation and brand positioning.
This policy envisions that by 2047, India will be having few National Institutes of Medical Devices Education and Research (NIMERs) on the lines of NIPERs; will be home & originator to 25 high-end futuristic technologies in medtech; and will have a medtech industry of $100-300 billion size with 10-12% of global market share.